1. Home
  2. FLGT vs ICHR Comparison

FLGT vs ICHR Comparison

Compare FLGT & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • ICHR
  • Stock Information
  • Founded
  • FLGT 2011
  • ICHR 1999
  • Country
  • FLGT United States
  • ICHR United States
  • Employees
  • FLGT N/A
  • ICHR N/A
  • Industry
  • FLGT Medical Specialities
  • ICHR Semiconductors
  • Sector
  • FLGT Health Care
  • ICHR Technology
  • Exchange
  • FLGT Nasdaq
  • ICHR Nasdaq
  • Market Cap
  • FLGT 639.0M
  • ICHR 727.6M
  • IPO Year
  • FLGT 2016
  • ICHR 2016
  • Fundamental
  • Price
  • FLGT $19.53
  • ICHR $17.21
  • Analyst Decision
  • FLGT Buy
  • ICHR Strong Buy
  • Analyst Count
  • FLGT 2
  • ICHR 6
  • Target Price
  • FLGT $24.00
  • ICHR $35.20
  • AVG Volume (30 Days)
  • FLGT 256.3K
  • ICHR 454.5K
  • Earning Date
  • FLGT 08-01-2025
  • ICHR 08-05-2025
  • Dividend Yield
  • FLGT N/A
  • ICHR N/A
  • EPS Growth
  • FLGT N/A
  • ICHR N/A
  • EPS
  • FLGT N/A
  • ICHR N/A
  • Revenue
  • FLGT $292,448,000.00
  • ICHR $892,122,000.00
  • Revenue This Year
  • FLGT $11.79
  • ICHR $14.18
  • Revenue Next Year
  • FLGT $10.45
  • ICHR $6.66
  • P/E Ratio
  • FLGT N/A
  • ICHR N/A
  • Revenue Growth
  • FLGT 1.71
  • ICHR 13.41
  • 52 Week Low
  • FLGT $14.57
  • ICHR $15.33
  • 52 Week High
  • FLGT $25.11
  • ICHR $42.70
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 40.94
  • ICHR 44.38
  • Support Level
  • FLGT $20.30
  • ICHR $17.58
  • Resistance Level
  • FLGT $21.07
  • ICHR $19.74
  • Average True Range (ATR)
  • FLGT 0.69
  • ICHR 0.81
  • MACD
  • FLGT -0.25
  • ICHR 0.04
  • Stochastic Oscillator
  • FLGT 1.15
  • ICHR 42.63

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

Share on Social Networks: